3-methoxytyramine has been researched along with Nervous System Disorders in 2 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vizuete, ML | 1 |
| Steffen, V | 1 |
| Machado, A | 1 |
| Cano, J | 1 |
| Naudin, B | 1 |
| Saligaut, C | 1 |
| Costentin, J | 1 |
2 other studies available for 3-methoxytyramine and Nervous System Disorders
| Article | Year |
|---|---|
1-Methyl-4-phenylpyridinium has greater neurotoxic effect after selenium deficiency than after vitamin E deficiency in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Dopamine; Eating; Free Radicals; Glutathione P | 1994 |
Influence of oxygen availability on the neurotoxic effect of 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atmospheric Pressure; Chromatography, High Pressure Liquid; | 1991 |